These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 20868205)
41. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Jain M; DerSimonian H; Brenner DA; Ngoy S; Teller P; Edge AS; Zawadzka A; Wetzel K; Sawyer DB; Colucci WS; Apstein CS; Liao R Circulation; 2001 Apr; 103(14):1920-7. PubMed ID: 11294813 [TBL] [Abstract][Full Text] [Related]
42. Granulocyte colony-stimulating factor treatment enhances the efficacy of cellular cardiomyoplasty with transplantation of embryonic stem cell-derived cardiomyocytes in infarcted myocardium. Cho SW; Gwak SJ; Kim IK; Cho MC; Hwang KK; Kwon JS; Choi CY; Yoo KJ; Kim BS Biochem Biophys Res Commun; 2006 Feb; 340(2):573-82. PubMed ID: 16376856 [TBL] [Abstract][Full Text] [Related]
43. Insulin-like growth factor-1 enhances the efficacy of myoblast transplantation with its multiple functions in the chronic myocardial infarction rat model. Kanemitsu N; Tambara K; Premaratne GU; Kimura Y; Tomita S; Kawamura T; Hasegawa K; Tabata Y; Komeda M J Heart Lung Transplant; 2006 Oct; 25(10):1253-62. PubMed ID: 17045939 [TBL] [Abstract][Full Text] [Related]
44. Post-ischaemic angiogenic therapy using in vivo prevascularized ascorbic acid-enriched myocardial artificial grafts improves heart function in a rat model. Martinez EC; Wang J; Lilyanna S; Ling LH; Gan SU; Singh R; Lee CN; Kofidis T J Tissue Eng Regen Med; 2013 Mar; 7(3):203-12. PubMed ID: 22034461 [TBL] [Abstract][Full Text] [Related]
46. Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Sekine H; Shimizu T; Dobashi I; Matsuura K; Hagiwara N; Takahashi M; Kobayashi E; Yamato M; Okano T Tissue Eng Part A; 2011 Dec; 17(23-24):2973-80. PubMed ID: 21875331 [TBL] [Abstract][Full Text] [Related]
47. Long-term cell survival and hemodynamic improvements after neonatal cardiomyocyte and satellite cell transplantation into healed myocardial cryoinfarcted lesions in rats. Huwer H; Winning J; Vollmar B; Welter C; Löhbach C; Menger MD; Schäfers HJ Cell Transplant; 2003; 12(7):757-67. PubMed ID: 14653622 [TBL] [Abstract][Full Text] [Related]
48. Both the transplantation of somatic cell nuclear transfer- and fertilization-derived mouse embryonic stem cells with temperature-responsive chitosan hydrogel improve myocardial performance in infarcted rat hearts. Lü S; Wang H; Lu W; Liu S; Lin Q; Li D; Duan C; Hao T; Zhou J; Wang Y; Gao S; Wang C Tissue Eng Part A; 2010 Apr; 16(4):1303-15. PubMed ID: 19905874 [TBL] [Abstract][Full Text] [Related]
50. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Shimizu T; Yamato M; Isoi Y; Akutsu T; Setomaru T; Abe K; Kikuchi A; Umezu M; Okano T Circ Res; 2002 Feb; 90(3):e40. PubMed ID: 11861428 [TBL] [Abstract][Full Text] [Related]
51. Use of bio-mimetic three-dimensional technology in therapeutics for heart disease. Serpooshan V; Zhao M; Metzler SA; Wei K; Shah PB; Wang A; Mahmoudi M; Malkovskiy AV; Rajadas J; Butte MJ; Bernstein D; Ruiz-Lozano P Bioengineered; 2014; 5(3):193-7. PubMed ID: 24637710 [TBL] [Abstract][Full Text] [Related]
52. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue. Tiburcy M; Didié M; Boy O; Christalla P; Döker S; Naito H; Karikkineth BC; El-Armouche A; Grimm M; Nose M; Eschenhagen T; Zieseniss A; Katschinksi DM; Hamdani N; Linke WA; Yin X; Mayr M; Zimmermann WH Circ Res; 2011 Oct; 109(10):1105-14. PubMed ID: 21921264 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of a peritoneal-generated cardiac patch in a rat model of heterotopic heart transplantation. Amir G; Miller L; Shachar M; Feinberg MS; Holbova R; Cohen S; Leor J Cell Transplant; 2009; 18(3):275-82. PubMed ID: 19558776 [TBL] [Abstract][Full Text] [Related]
54. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Wang F; Guan J Adv Drug Deliv Rev; 2010 Jun; 62(7-8):784-97. PubMed ID: 20214939 [TBL] [Abstract][Full Text] [Related]
55. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction. Rojas SV; Kensah G; Rotaermel A; Baraki H; Kutschka I; Zweigerdt R; Martin U; Haverich A; Gruh I; Martens A PLoS One; 2017; 12(5):e0173222. PubMed ID: 28493867 [TBL] [Abstract][Full Text] [Related]
56. New directions in strategies using cell therapy for heart disease. Itescu S; Schuster MD; Kocher AA J Mol Med (Berl); 2003 May; 81(5):288-96. PubMed ID: 12698252 [TBL] [Abstract][Full Text] [Related]
57. Engineered cardiac tissues for in vitro assessment of contractile function and repair mechanisms. Kim DE; Lee EJ; Martens TP; Kara R; Chaudhry HW; Itescu S; Costa KD Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():849-52. PubMed ID: 17946863 [TBL] [Abstract][Full Text] [Related]
58. Electromechanical Conditioning of Adult Progenitor Cells Improves Recovery of Cardiac Function After Myocardial Infarction. Llucià-Valldeperas A; Soler-Botija C; Gálvez-Montón C; Roura S; Prat-Vidal C; Perea-Gil I; Sanchez B; Bragos R; Vunjak-Novakovic G; Bayes-Genis A Stem Cells Transl Med; 2017 Mar; 6(3):970-981. PubMed ID: 28297585 [TBL] [Abstract][Full Text] [Related]
59. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Ding L; Dong L; Chen X; Zhang L; Xu X; Ferro A; Xu B Circulation; 2009 Sep; 120(9):764-73. PubMed ID: 19687354 [TBL] [Abstract][Full Text] [Related]